whytestocks
6 years ago
News: $ORPN Bioblast Announces Effectiveness of Eight to One Reverse Split
Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...
Find out more https://marketwirenews.com/news-releases/bioblast-announces-effectiveness-of-eight-to-one-reverse-split-7810132.html